dddd
PublishedSeptember 9, 2014

Welcome to the New Patent Progress

If you’re a regular reader of Patent Progress, you’ve noticed the new look. We’ve tried to make the site cleaner and easier to use.

While we’ve done our best to test it thoroughly, if you do happen to notice a problem, we’d appreciate you letting us know.

Update: We have also updated the daily newsletter. You don’t need to resubscribe, but please make sure that emails from [email protected] aren’t being sent to your spam folder. If you have questions, please contact us.

Matt Levy

Previously, Matt was patent counsel at the Computer & Communications Industry Association

More Posts

How Challenging Low Quality Patents is Lowering Drug Prices

The FTC made headlines in May when it announced it was challenging over 300 “junk” patents in the FDA’s “Orange Book,” including patents on popular drugs like Ozempic and Victoza. With this ...

Incremental Progress on Valve

In March, U.S. Patent and Trademark Office Director Kathi Vidal vacated earlier Patent Trial and Appeal Board (PTAB) decisions that denied patent validity challenges brought by Honda Motor Co., Genera...

Congress Wants to Revive Patents but May Strangle Innovation and Damage Health Care Access Instead

This post, written by Wayne Brough, initially appeared in the R Street’s Real Solutions Blog. Patent eligibility, or the fundamental question of what is patentable, is currently under congression...

Subscribe to Patent Progress

No spam. Unsubscribe anytime.